- ISIN
- US43906K1007
- CUSIP
- 43906K100
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Apr 18, 2019
Highlights
- Market Cap
- $14.40M
- Enterprise Value
- -$19.29M
- Total Revenue (TTM)
- $14.86M
- Gross Profit (TTM)
- $14.86M
- EBITDA (TTM)
- -$53.86M
- Year Range
- $0.81 - $1.20
- Target Price
- $3.00
- ROA (TTM)
- -106.26%
- ROE (TTM)
- -195.24%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HOOK Performance Chart
Loading charts...
Returns By Period
HOOKIPA Pharma Inc.
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.79%
- 1M
- 1.13%
- 6M
- 7.71%
- YTD
- 9.79%
- 1Y
- 20.06%
- 3Y*
- 18.60%
- 5Y*
- 11.43%
- 10Y*
- 13.27%
HOOK Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.42% | 5.53% | 0.00% | 11.43% | -2.56% | 0.88% | 28.78% | ||||||
| 2025 | -2.49% | -21.94% | -29.41% | -12.04% | 67.37% | -21.07% | -28.84% | 1.90% | 1.65% | -4.32% | 0.68% | 0.22% | -55.57% |
| 2024 | -23.32% | 23.65% | -7.29% | 24.62% | -10.52% | -25.47% | -1.66% | -10.14% | -17.78% | -11.86% | -33.51% | -20.24% | -75.19% |
| 2023 | 23.46% | -13.50% | -14.91% | 35.87% | 31.00% | -32.82% | -10.23% | -17.09% | -5.95% | -29.87% | 31.71% | 42.36% | 0.00% |
| 2022 | -35.62% | 60.00% | -5.00% | -34.21% | 14.67% | -5.23% | -15.95% | 8.76% | -10.07% | -3.73% | -17.83% | -23.58% | -65.24% |
| 2021 | -3.61% | 10.76% | 13.60% | 0.67% | 23.26% | -45.12% | -15.61% | -10.87% | -14.51% | -17.32% | -33.68% | -27.86% | -78.99% |
Benchmark Metrics
HOOKIPA Pharma Inc. has an annualized alpha of -40.82%, beta of 1.18, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since April 18, 2019.
- This stock participated in 193.26% of S&P 500 Index downside but only -38.88% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -40.82%
- Beta
- 1.18
- R²
- 0.08
- Upside Capture
- -38.88%
- Downside Capture
- 193.26%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for HOOKIPA Pharma Inc. (HOOK) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HOOK | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.29 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.21 | — |
| Martin ratioReturn relative to average drawdown | — | 9.61 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the HOOKIPA Pharma Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the HOOKIPA Pharma Inc. was 99.62%, occurring on Apr 10, 2025. The portfolio has not yet recovered.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.62%Apr 2025 | 3y 10mo | — | 5y 1moMay 2021 - now |
COVID crash2020 | -58.74%Mar 2020 | 11mo 3d | 1y 3d | 1y 11moApr 2019 - Mar 2021 |
2021 correction2021 | -18.37%Apr 2021 | 28d | 17d | 1mo 15dMar 2021 - May 2021 |
2021 pullback2021 | -0.66%May 2021 | 0s | 3d | 3dMay 2021 - May 2021 |
Drawdown Indicators
| HOOK | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -1.24% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.71% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.09% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of HOOKIPA Pharma Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how HOOKIPA Pharma Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HOOK in comparison with other companies in the Biotechnology industry. Currently, HOOK has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with HOOK
Add HOOKIPA Pharma Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HOOK